Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Krishna Institute of Medical Sciences Ltd Performance

Today's Low
1,970.00
arrowIcon
Today's High
2,048.70
52 Wk Low
1,457.05
arrowIcon
52 Wk High
2,356.40


Open

2019

Traded Value (Cr)

22.29 Cr

Prev. Close

2019.95

VWAP

2007.84

Volume

57,774

Face Value

10

Krishna Institute of Medical Sciences Ltd Fundamentals

Market Cap
₹ 16,194 Cr
P/E Ratio (TTM)
47.92
P/B Ratio
8.93
Debt to Equity
0.53
ROE
18.87 %
EPS (TTM)
42.23
Dividend Yield
0.00%
Book Value
226.57

Click here to know more about Fundamentals

Krishna Institute of Medical Sciences Ltd Financials

Krishna Institute of Medical Sciences Ltd Financials

Krishna Institute of Medical Sciences Ltd Shareholding Pattern

Held By Dec 2023 Sep 2023 Jun 2023 Mar 2023
Promoters 38.82 % 38.84 % 38.84 % 38.84 %
Mutual Funds 27.36 % 27.01 % 27.40 % 21.68 %
FII 15.27 % 14.25 % 13.15 % 19.40 %
Retail 10.84 % 11.15 % 11.22 % 11.10 %
Others 7.70 % 8.75 % 9.38 % 8.97 %

Promoters

38.82%

Mutual Funds

27.36%

FII

15.27%

Retail

10.84%

Others

7.70%

Promoters

38.84%

Mutual Funds

27.01%

FII

14.25%

Retail

11.15%

Others

8.75%

Promoters

38.84%

Mutual Funds

27.40%

FII

13.15%

Retail

11.22%

Others

9.38%

Promoters

38.84%

Mutual Funds

21.68%

FII

19.40%

Retail

11.10%

Others

8.97%

Resistance and Support

₹2,008.53

PIVOT

resistance-arrow
Resistance
First Resistance₹2,028.167
Second Resistance₹2,053.583
Third Resistance₹2,073.217
support-arrow
Support
First Resistance₹1,983.117
Second Resistance₹1,963.483
Third Resistance₹1,938.067
RSI45.482
MACD0.372
ADX47.077
CCI-64.160

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day57,77491,80281.47
Week69,00771,54576.62
1 Month78,68656,64166.28
6 Months57,77443,58975.45

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company. Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 2,120 beds, including 1,705 operational beds. The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ('NABH'). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ('NABL'). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award', by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ('AHPI') for nursing excellence, in 2015 and for Patient Friendly Hospital', in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016. In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board. During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.

Managing Director

Founded

1973

NSE Symbol

KIMS

Krishna Institute of Medical Sciences Ltd Management

NameDesignation
Bhaskara Rao BollineniChairman / Executive Director
Abhinay BollineniExecutive Director & CEO
Dandamudi AnithaWTD & Executive Director
Rajeswara Rao GanduIndependent Non Exe. Director
Saumen ChakrabortyIndependent Non Exe. Director
Pankaj VaishIndependent Non Exe. Director
Ratna Kishore KazaIndependent Non Exe. Director
J V RamuduIndependent Non Exe. Director
Y Prameela RaniIndependent Non Exe. Director
Shantanu RastogiNon Executive Director
Y Prameela RaniIndependent Director
Adwik BollineniAdditional Director

Krishna Institute of Medical Sciences Ltd News

KIMS Hospitals edges higher after acquiring land for new hospital in Thane
Krishna Institute of Medical Sciences rose 1.14% to Rs 2010.30 after the company announced the signing of definitive agreement for the acquisition of land on 99-year lease and purchase of the building thereon for setting up a new hospital at Thane.
Krishna Institute of Medical Sciences acquires land for new hospital in Thane
Krishna Institute of Medical Sciences consolidated net profit declines 5.45% in the December 2023 quarter
Sales rise 7.77% to Rs 605.84 crore
Volumes soar at Krishna Institute of Medical Sciences Ltd counter
Krishna Institute of Medical Sciences Ltd clocked volume of 11.67 lakh shares by 10:47 IST on BSE, a 223.13 times surge over two-week average daily volume of 5231 shares
KIMS slips as Q3 PAT slides 6% YoY To Rs 72 cr
Krishna Institute of Medical Sciences (KIMS) fell 3.10% to Rs 2,082 after the company’s consolidated net profit declined 5.45% to Rs 71.84 crore in Q3 FY24 as compared to Rs 75.98 crore posted in Q3 FY23.
Krishna Institute of Medical Sciences announces cessation of director
Krishna Institute of Medical Sci. announces board meeting date
On 3 February 2024
Krishna Institute of Medical Sciences hikes stake in Sarvejana Healthcare
Krishna Institute of Medical Sciences announces cessation of director
With effect from 07 January 2024
Board of Krishna Institute of Medical Sciences appoints director
At meeting held on 28 November 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 92,116 Cr
₹ 6,406.55
(-1.28 %)
92.21
MAXHEALTH₹ 84,600 Cr
₹ 870.45
(0.71 %)
147.87
MEDANTA₹ 37,545 Cr
₹ 1,398.30
(-1.92 %)
107.37
FORTIS₹ 32,572 Cr
₹ 431.45
(-0.54 %)
426.14
NH₹ 26,329 Cr
₹ 1,288.40
(-1.88 %)
73.55

Krishna Institute of Medical Sciences Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Krishna Institute of Medical Sciences Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Krishna Institute of Medical Sciences Ltd's share price is ₹1,977.95 as of April 12, 2024

Krishna Institute of Medical Sciences Ltd's P/E ratio is 47.92 times as of April 12, 2024.

Krishna Institute of Medical Sciences Ltd's most recent financial reports indicate a price-to-book ratio of 8.93, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Krishna Institute of Medical Sciences Ltd's market is 16,195 Cr as on April 12, 2024.

The current financial records of Krishna Institute of Medical Sciences Ltd show a 18.87% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Krishna Institute of Medical Sciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Krishna Institute of Medical Sciences Ltd's 52-week high and low as of April 12, 2024 are ₹2048.7 and ₹1970 respectively.

As of the Dec 2023 quarter, the promoter shareholding in Krishna Institute of Medical Sciences Ltd stands at 38.82%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 14.25% to 15.27%.